Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Plank

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Cell|January 7, 2020
The Aspartic Protease Ddi1 Contributes to DNA-Protein Crosslink Repair in YeastNataliia Serbyn, Audrey Noireterre, Ivona Bagdiul, et al.
Anesthesiology|March 27, 2003
Local anesthetics impair human granulocyte phagocytosis activity, oxidative burst, and CD11b expression in response to Staphylococcus aureusRalph-Thomas Kiefer, Annette Ploppa, Wolfgang A Krueger, et al.
Proteomics|June 6, 2015
Expanding the yeast protein arginine methylomeMichael Plank, Roman Fischer, Vincent Geoghegan, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2020
Chemical Genetics of AGC-kinases Reveals Shared Targets of Ypk1, Protein Kinase A and Sch9Michael Plank, Mariya Perepelkina, Markus Müller, et al.
Scientific Reports|January 18, 2013
An analysis and validation pipeline for large-scale RNAi-based screensMichael Plank, Guang Hu, A Sofia Silva, et al.
Microbiology Spectrum|March 1, 2024
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys systemNoemi Castelletti, Ivana Paunovic, Raquel Rubio-Acero, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-SMohamed I M Ahmed, Michael Plank, Noemi Castelletti, et al.
BMC Infectious Diseases|July 13, 2023
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variantRonan Le Gleut, Michael Plank, Peter Pütz, et al.
Frontiers in Immunology|December 30, 2022
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infectionsMohamed Ibraheem Mahmoud Ahmed, Paulina Diepers, Christian Janke, et al.
Viruses|July 29, 2023
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare WorkersChristina Reinkemeyer, Yeganeh Khazaei, Maximilian Weigert, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Cell|January 7, 2020
The Aspartic Protease Ddi1 Contributes to DNA-Protein Crosslink Repair in YeastNataliia Serbyn, Audrey Noireterre, Ivona Bagdiul, et al.
Anesthesiology|March 27, 2003
Local anesthetics impair human granulocyte phagocytosis activity, oxidative burst, and CD11b expression in response to Staphylococcus aureusRalph-Thomas Kiefer, Annette Ploppa, Wolfgang A Krueger, et al.
Proteomics|June 6, 2015
Expanding the yeast protein arginine methylomeMichael Plank, Roman Fischer, Vincent Geoghegan, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2020
Chemical Genetics of AGC-kinases Reveals Shared Targets of Ypk1, Protein Kinase A and Sch9Michael Plank, Mariya Perepelkina, Markus Müller, et al.
Scientific Reports|January 18, 2013
An analysis and validation pipeline for large-scale RNAi-based screensMichael Plank, Guang Hu, A Sofia Silva, et al.
Microbiology Spectrum|March 1, 2024
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys systemNoemi Castelletti, Ivana Paunovic, Raquel Rubio-Acero, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-SMohamed I M Ahmed, Michael Plank, Noemi Castelletti, et al.
BMC Infectious Diseases|July 13, 2023
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variantRonan Le Gleut, Michael Plank, Peter Pütz, et al.
Frontiers in Immunology|December 30, 2022
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infectionsMohamed Ibraheem Mahmoud Ahmed, Paulina Diepers, Christian Janke, et al.
Viruses|July 29, 2023
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare WorkersChristina Reinkemeyer, Yeganeh Khazaei, Maximilian Weigert, et al.
Pageof 3